KEPIVANCE

This brand name is authorized in United States. It is also authorized in Estonia, Lithuania.

Active ingredients

The drug KEPIVANCE contains one active pharmaceutical ingredient (API):

1
UNII QMS40680K6 - PALIFERMIN
 
Read more about FGF-7

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V03AF08 Palifermin V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AF Detoxifying agents for antineoplastic treatment
Discover more medicines within V03AF08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1218844
LT Valstybinė vaistų kontrolės tarnyba 1028998
US FDA, National Drug Code 66658-112

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈